Survival Outcomes in Patients With Advanced Hepatocellular Carcinoma Treated With Drug-Eluting Bead Chemoembolization

Survival Outcomes in Patients With Advanced Hepatocellular Carcinoma Treated With Drug-Eluting Bead Chemoembolization is organized by American Roentgen Ray Society (ARRS).

Date of issuance: January 23, 2015
Date of expiration: January 22, 2021

Estimated time to complete the activity: 1 hour(s)

Accreditation:
Designation Statement
The ARRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Goals and Objectives:
After completing the material in this article, the learner should be able to:
• Understand the criteria for tumor staging and treatment of hepatocellular carcinoma.
• Understand the treatment options and survival patterns of advanced hepatocellular carcinoma.